Cargando…
NFYA promotes the anti-tumor effects of gluconeogenesis in hepatocellular carcinoma through the regulation of PCK1 expression
Reprogramming of glucose metabolism occurs in many human tumor types, and one of these, gluconeogenesis, is known to exhibit anti-tumor effects in hepatocellular carcinoma (HCC). The transcription factor NFYA regulates gluconeogenesis in the normal liver tissue, but the function of the NFYA-gluconeo...
Autores principales: | Tsujimoto, Goki, Ito, Rin, Yoshikawa, Kei, Ueki, Chihiro, Okada, Nobuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452718/ https://www.ncbi.nlm.nih.gov/pubmed/36092708 http://dx.doi.org/10.3389/fcell.2022.983599 |
Ejemplares similares
-
NFYA promotes malignant behavior of triple-negative breast cancer in mice through the regulation of lipid metabolism
por: Okada, Nobuhiro, et al.
Publicado: (2023) -
SHP-1 phosphatase acts as a coactivator of PCK1 transcription to control gluconeogenesis
por: Kumar, Amit, et al.
Publicado: (2023) -
Hepatic retinaldehyde deficiency is involved in diabetes deterioration by enhancing PCK1- and G6PC-mediated gluconeogenesis
por: Yang, Hanyu, et al.
Publicado: (2023) -
6-Phosphogluconolactonase Promotes Hepatocellular Carcinogenesis by Activating Pentose Phosphate Pathway
por: Li, Changzheng, et al.
Publicado: (2021) -
Possible Therapeutic Utility of anti-Cell Adhesion Molecule 1 Antibodies for Malignant Pleural Mesothelioma
por: Hagiyama, Man, et al.
Publicado: (2022)